ન્યુરોએન્ડોક્રાઇન ટ્યુમર
Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors
ક્યાં જવું
ભારતમાં 2 hospitals છે જે આ trial માટે patients લઈ રહ્યા છે.
રજિસ્ટ્રી સમરી (ટેકનિકલ)
Gastro-enteropancreatic Neuro-endocrine tumors (GEP-NETs) are rare slow-growing cancers which commonly involve the abdominal organs like liver, stomach, intestines and pancreas. Their incidence has been documented to have increased over the last decade, thus resulting in treatment options being developed to treat these cancers. These cancers spread commonly to the liver, followed by lungs, bones and other sites. Depending on the extent of disease seen on scan, treatment is planned. Patients are advised Peptide Receptor Radionuclide Therapy (PRRT), which is the current standard of treatment for…
Sponsor: Tata Memorial Hospital
ClinicalTrials.gov પર NCT07404176
રજિસ્ટ્રી પર છેલ્લે 11 Feb 2026 ના રોજ અપડેટ થયું · અમે 20 Oct 2026 ના રોજ વાંચ્યું